Advertisement
Advances in Pediatrics

Inflammatory Bowel Disease in Children and Adolescents

  • Nathan S. Rubalcava
    Affiliations
    Section of Pediatric Surgery, Department of Surgery, University of Michigan, Mott Children's Hospital, 1540 East Hospital Drive SPC 4217, Ann Arbor, MI 48109 – 4217, USA
    Search for articles by this author
  • Samir K. Gadepalli
    Correspondence
    Corresponding author. Section of Pediatric Surgery, Department of Surgery, University of Michigan, Mott Children's Hospital, 1540 East Hospital Drive SPC 4217, Ann Arbor, MI 48109 – 4217.
    Affiliations
    Section of Pediatric Surgery, Department of Surgery, University of Michigan, Mott Children's Hospital, 1540 East Hospital Drive SPC 4217, Ann Arbor, MI 48109 – 4217, USA

    Susan B. Meister Child Health Evaluation and Research Center, Michigan Medicine, Ann Arbor, MI 48109, USA
    Search for articles by this author
      Incidence of inflammatory bowel disease (IBD) is increasing in developed countries, and children are being diagnosed at earlier ages.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kaplan G.G.
        The global burden of IBD: from 2015 to 2025.
        Nat Rev Gastroenterol Hepatol. 2015; 12: 720-727
        • Abramson O.
        • Durant M.
        • Mow W.
        • et al.
        Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006.
        J Pediatr. 2010; 157: 233-239.e1
        • Molodecky N.A.
        • Soon I.S.
        • Rabi D.M.
        • et al.
        Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.
        Gastroenterology. 2012; 142: 46-54.e42
        • Ye Y.
        • Manne S.
        • Treem W.R.
        • et al.
        Prevalence of inflammatory bowel disease in pediatric and adult populations: recent estimates from large national databases in the United States, 2007-2016.
        Inflamm Bowel Dis. 2020; 26: 619-625
        • Victoria C.R.
        • Sassaki L.Y.
        • Nunes H.R.D.C.
        Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil.
        Arq Gastroenterol. 2009; 46: 20-25
        • Ng S.C.
        • Tang W.
        • Ching J.Y.
        • et al.
        Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and Colitis Epidemiology study.
        Gastroenterology. 2013; 145: 158-165.e2
        • Khor B.
        • Gardet A.
        • Xavier R.J.
        Genetics and pathogenesis of inflammatory bowel disease.
        Nature. 2011; 474: 307-317
        • Xavier R.J.
        • Podolsky D.K.
        Unravelling the pathogenesis of inflammatory bowel disease.
        Nature. 2007; 448: 427-434
        • Hugot J.P.
        • Dumay A.
        • Barreau F.
        • et al.
        Crohn's disease: is the cold chain hypothesis still hot?.
        J Crohns Colitis. 2020; 26: 1-15
        • Ng S.C.
        • Shi H.Y.
        • Hamidi N.
        • et al.
        Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
        Lancet. 2017; 390: 2769-2778
        • Halfvarson J.
        • Brislawn C.J.
        • Lamendella R.
        • et al.
        Dynamics of the human gut microbiome in inflammatory bowel disease.
        Nat Microbiol. 2017; 2: 1-7
        • Pascal V.
        • Pozuelo M.
        • Borruel N.
        • et al.
        A microbial signature for Crohn's disease.
        Gut. 2017; 66: 813-822
        • Najarian R.M.
        • Ashworth L.A.
        • Wang H.H.
        Microscopic/‘“ Backwash ”’ ileitis and its association with colonic disease in new onset pediatric ulcerative colitis.
        J Pediatr Gastroenterol Nutr. 2019; 68: 835-840
        • Benchimol E.I.
        • Bernstein C.N.
        • Bitton A.
        • et al.
        Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases.
        Am J Gastroenterol. 2017; 112: 1120-1134
        • Kugathasan S.
        • Judd R.H.
        • Hoffmann R.G.
        • et al.
        Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study.
        J Pediatr. 2003; 143: 525-531
        • Fuller M.K.
        Pediatric inflammatory bowel disease.
        Surg Clin North Am. 2019; 99: 1177-1183
        • Adler J.
        • Dong S.
        • Eder S.J.
        • et al.
        Perianal Crohn disease in a large multicenter pediatric collaborative.
        J Pediatr Gastroenterol Nutr. 2017; 64: e117-e124
        • Singer A.A.M.
        • Gadepalli S.K.
        • Eder S.J.
        • et al.
        Fistulizing Crohn's disease presenting after surgery on a perianal lesion.
        Pediatrics. 2016; 137https://doi.org/10.1542/peds.2015-2878
        • Childers R.E.
        • Eluri S.
        • Vazquez C.
        • et al.
        Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis.
        J Crohns Colitis. 2014; 8: 1480-1497
        • Rosen M.J.
        • Dhawan A.
        • Saeed S.A.
        Inflammatory bowel disease in children and adolescents.
        JAMA Pediatr. 2015; 169: 1053-1060
        • Aloi M.
        • Cucchiara S.
        Extradigestive manifestations of IBD in pediatrics.
        Eur Rev Med Pharmacol Sci. 2009; 13: 23-32
        • Brown S.R.
        • Coviello L.C.
        Extraintestinal manifestations associated with inflammatory bowel disease.
        Surg Clin North Am. 2015; 95: 1245-1259
        • Hyams J.
        • Markowitz J.
        • Otley A.
        • et al.
        Evaluation of the pediatric Crohn disease activity index: a prospective multicenter experience.
        J Pediatr Gastroenterol Nutr. 2005; 41: 416-421
        • Turner D.
        • Otley A.R.
        • Mack D.
        • et al.
        Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.
        Gastroenterology. 2007; 133: 423-432
        • Arai K.
        Very early-onset inflammatory bowel disease: a challenging field for pediatric gastroenterologists.
        Pediatr Gastroenterol Hepatol Nutr. 2020; 23: 411
        • Kotlarz D.
        • Beier R.
        • Murugan D.
        • et al.
        Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
        Gastroenterology. 2012; 143: 347-355
        • Zaidi D.
        • Wine E.
        Regulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κβ) in inflammatory bowel diseases.
        Front Pediatr. 2018; 6: 1-9
        • Ouahed J.
        • Spencer E.
        • Kotlarz D.
        • et al.
        Very early onset inflammatory bowel disease: a clinical approach with a focus on the role of genetics and underlying immune deficiencies.
        Inflamm Bowel Dis. 2020; 26: 820-842
        • Kim A.
        • Gadepalli S.
        Inflammatory bowel disease.
        in: Davenport M. Geiger J. Operative pediatric surgery. 8th edition. CRC Press, Boca Raton2020: 440-451
        • Uhlig H.H.
        Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
        Gut. 2013; 62: 1795-1805
        • Kelsen J.R.
        • Russo P.
        • Sullivan K.E.
        Early-onset inflammatory bowel disease.
        Immunol Allergy Clin North Am. 2019; 39: 63-79
        • Mack D.R.
        • Langton C.
        • Markowitz J.
        • et al.
        Laboratory values for children with newly diagnosed inflammatory bowel disease.
        Pediatrics. 2007; 119: 1113-1119
        • Alper A.
        • Zhang L.
        • Pashankar D.S.
        Correlation of erythrocyte sedimentation rate and C-reactive protein with pediatric inflammatory bowel disease activity.
        J Pediatr Gastroenterol Nutr. 2017; 65: e25-e27
        • Watson T.A.
        • Petit P.
        • Augdal T.A.
        • et al.
        European Society of Paediatric Radiology abdominal imaging task force: statement on imaging in very early onset inflammatory bowel disease.
        Pediatr Radiol. 2019; 49: 841-848
        • Levine A.
        • Koletzko S.
        • Turner D.
        • et al.
        ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.
        J Pediatr Gastroenterol Nutr. 2014; 58: 795-806
        • Matsui T.
        [Natural history of inflammatory bowel disease].
        Nihon Shokakibyo Gakkai Zasshi. 2007; 104: 1172-11782
        • Tung J.
        • Loftus E.V.
        • Freese D.K.
        • et al.
        A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis.
        Inflamm Bowel Dis. 2006; 12: 1093-1100
        • Cohen S.A.
        • Aloi M.
        • Arumugam R.
        • et al.
        Enteric-coated budesonide for the induction and maintenance of remission of Crohn's disease in children.
        Curr Med Res Opin. 2017; 33: 1261-1268
        • Quiros J.A.
        • Heyman M.B.
        • Pohl J.F.
        • et al.
        Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study.
        J Pediatr Gastroenterol Nutr. 2009; 49: 571-579
        • Zeisler B.
        • Lerer Ã.T.
        • Markowitz J.
        • et al.
        Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis.
        J Pediatr Gastroenterol Nutr. 2013; 56: 12-18
        • Ruemmele F.M.
        • Veres G.
        • Kolho K.L.
        • et al.
        Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.
        J Crohns Colitis. 2014; 8: 1179-1207
        • Lim W.C.
        • Wang Y.
        • Macdonald J.K.
        • et al.
        Aminosalicylates for induction of remission or response in Crohn's disease.
        Cochrane Database Syst Rev. 2016; https://doi.org/10.1002/14651858.CD008870.pub2
        • Markowitz J.
        • Grancher K.
        • Kohn N.
        • et al.
        A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease.
        Gastroenterology. 2000; 119: 895-902
        • Lee M.N.
        • Kang B.
        • Choi S.Y.
        • et al.
        Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.
        Inflamm Bowel Dis. 2015; 21: 1054-1062
        • Day A.S.
        • Gulati A.S.
        • Patel N.
        • et al.
        The role of combination therapy in pediatric inflammatory bowel disease: a clinical report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
        J Pediatr Gastroenterol Nutr. 2018; 66: 361-368
        • Hanauer S.B.
        • Feagan B.G.
        • Lichtenstein G.R.
        • et al.
        Maintenance infliximab in Crohn's disease: the ACCENT I randomised trial.
        Lancet. 2002; 359: 1541-1549
        • Hyams J.
        • Crandall W.
        • Kugathasan S.
        • et al.
        Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
        Gastroenterology. 2007; 132: 863-873
        • Adler J.
        • Lin C.C.
        • Gadepalli S.K.
        • et al.
        Association between steroid-sparing therapy and the risk of perianal fistulizing complications among young patients with Crohn disease.
        JAMA Netw Open. 2020; 3: e207378
        • Lee M.J.
        • Parker C.E.
        • Taylor S.R.
        • et al.
        Efficacy of medical therapies for fistulizing Crohn's disease: systematic review and meta-analysis.
        Clin Gastroenterol Hepatol. 2018; 16: 1879-1892
        • Corica D.
        • Romano C.
        Biological therapy in pediatric inflammatory bowel disease a systematic review.
        J Clin Gastroenterol. 2017; 51: 100-110
        • Ledder O.
        • Assa A.
        • Levine A.
        • et al.
        Vedolizumab in paediatric inflammatory bowel disease: a retrospective multi-centre experience from the paediatric IBD porto group of ESPGHAN.
        J Crohns Colitis. 2017; 11: 1230-1237
        • Biemans V.B.C.
        • van der Woude C.J.
        • Dijkstra G.
        • et al.
        Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment.
        Aliment Pharmacol Ther. 2020; 52: 123-134
        • Grossi V.
        • Lerer T.
        • Griffiths A.
        • et al.
        Concomitant use of immunomodulators affects the durability of infliximab therapy in children with Crohn's disease.
        Clin Gastroenterol Hepatol. 2015; 13: 1748-1756
        • Ponsioen C.Y.
        • de Groof E.J.
        • Eshuis E.J.
        • et al.
        Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
        Lancet Gastroenterol Hepatol. 2017; 2: 785-792
        • El-Matary W.
        • Walters T.D.
        • Huynh H.Q.
        • et al.
        Higher postinduction infliximab serum trough levels are associated with healing of fistulizing perianal Crohn's disease in children.
        Inflamm Bowel Dis. 2019; 25: 150-155
        • Tsoraides S.S.
        • Pearl R.H.
        • Stanfill A.B.
        • et al.
        Incision and loop drainage: a minimally invasive technique for subcutaneous abscess management in children.
        J Pediatr Surg. 2010; 45: 606-609
        • Yassin N.A.
        • Askari A.
        • Warusavitarne J.
        • et al.
        Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease.
        Aliment Pharmacol Ther. 2014; 40: 741-749
        • Slieker J.C.
        • Daams F.
        • Mulder I.M.
        • et al.
        Systematic review of the technique of colorectal anastomosis.
        JAMA Surg. 2013; 148: 190-201
        • Kennedy R.D.
        • Zarroug A.E.
        • Moir C.R.
        • et al.
        Ileal pouch anal anastomosis in pediatric familial adenomatous polyposis: a 24-year review of operative technique and patient outcomes.
        J Pediatr Surg. 2014; 49: 1409-1412
        • Traynor M.D.
        • Yonkus J.
        • Moir C.R.
        • et al.
        Altering the traditional approach to restorative proctocolectomy after subtotal colectomy in pediatric patients.
        J Laparoendosc Adv Surg Tech A. 2019; 29: 1207-1211
        • Zittan E.
        • Wong-Chong N.
        • Ma G.W.
        • et al.
        Modified two-stage ileal pouch-anal anastomosis results in lower rate of anastomotic leak compared with traditional two-stage surgery for ulcerative colitis.
        J Crohns Colitis. 2016; 10: 766-772
        • Park K.T.
        • Sin A.
        • Wu M.
        • et al.
        Utilization trends of anti-TNF agents and health outcomes in adults and children with inflammatory bowel diseases: a single-center experience.
        Inflamm Bowel Dis. 2014; 20: 1242-1249
        • Ihekweazu F.D.
        • Fofanova T.
        • Palacios R.
        • et al.
        Progression to colectomy in the era of biologics: a single center experience with pediatric ulcerative colitis.
        J Pediatr Surg. 2020; 55: 1815-1823
        • Kunitake H.
        • Hodin R.
        • Shellito P.C.
        • et al.
        Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications.
        J Gastrointest Surg. 2008; 12: 1730-1737
        • Narula N.
        • Charleton D.
        • Marshall J.K.
        Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease.
        Aliment Pharmacol Ther. 2013; 37: 1057-1064
        • Mitsuya J.B.
        • Gonzalez R.
        • Thomas R.
        • et al.
        The effect of biologics on postoperative complications in children with inflammatory bowel disease and bowel resection.
        J Pediatr Gastroenterol Nutr. 2019; 68: 334-338
        • Koivusalo A.
        • Pakarinen M.P.
        • Rintala R.J.
        Surgical complications in relation to functional outcomes after ileoanal anastomosis in pediatric patients with ulcerative colitis.
        J Pediatr Surg. 2007; 42: 290-295
        • Pakarinen M.P.
        • Natunen J.
        • Ashorn M.
        • et al.
        Long-term outcomes of restorative proctocolectomy in children with ulcerative colitis.
        Pediatrics. 2009; 123: 1377-1382
        • Rintala R.J.
        • Lindahl H.G.
        Proctocolectomy and J-pouch ileo-anal anastomosis in children.
        J Pediatr Surg. 2002; 37: 66-70
        • Faye A.S.
        • Oh A.
        • Kumble L.D.
        • et al.
        Fertility impact of initial operation type for female ulcerative colitis patients.
        Inflamm Bowel Dis. 2020; 26: 1368-1376
        • Rajaratnam S.G.
        • Eglinton T.W.
        • Hider P.
        • et al.
        Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review.
        Int J Colorectal Dis. 2011; 26: 1365-1374
        • Purewal S.
        • Chapman S.
        • Czuber-Dochan W.
        • et al.
        Systematic review: the consequences of psychosocial effects of inflammatory bowel disease on patients′ reproductive health.
        Aliment Pharmacol Ther. 2018; 48: 1202-1212
        • Ban L.
        • Tata L.J.
        • Humes D.J.
        • et al.
        Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study.
        Aliment Pharmacol Ther. 2015; 42: 855-866
        • Allocca M.
        • Gilardi D.
        • Fiorino G.
        • et al.
        Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men.
        Eur J Gastroenterol Hepatol. 2018; 30: 316-322
        • Tavernier N.
        • Fumery M.
        • Peyrin-Biroulet L.
        • et al.
        Systematic review: fertility in non-surgically treated inflammatory bowel disease.
        Aliment Pharmacol Ther. 2013; 38: 847-853
        • Wierstra K.
        • Sutton R.
        • Bal J.
        • et al.
        Innovative online educational portal improves disease-specific reproductive knowledge among patients with inflammatory bowel disease.
        Inflamm Bowel Dis. 2018; 24: 2483-2493
        • Heuschkel R.
        • Salvestrini C.
        • Beattie R.M.
        • et al.
        Guidelines for the management of growth failure in childhood inflammatory bowel disease.
        Inflamm Bowel Dis. 2008; 14: 839-849
        • Assa A.
        • Ish-Tov A.
        • Rinawi F.
        • et al.
        School attendance in children with functional abdominal pain and inflammatory bowel diseases.
        J Pediatr Gastroenterol Nutr. 2015; 61: 553-557
        • Kunz J.H.
        • Greenley R.N.
        • Howard M.
        Maternal, paternal, and family health-related quality of life in the context of pediatric inflammatory bowel disease.
        Qual Life Res. 2011; 20: 1197-1204
        • Carreon S.A.
        • Bugno L.T.
        • Wojtowicz A.A.
        • et al.
        School functioning in adolescents with inflammatory bowel diseases: an examination of disease and demographic correlates.
        Inflamm Bowel Dis. 2018; 24: 1624-1631
        • Bernstein C.N.
        • Blanchard J.F.
        • Kliewer E.
        • et al.
        Cancer risk in patients with inflammatory bowel disease: a population-based study.
        Cancer. 2001; 91: 854-862
        • Herrinton L.J.
        • Liu L.
        • Levin T.R.
        • et al.
        Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.
        Gastroenterology. 2012; 143: 382-389
        • Grover Z.
        • Burgess C.
        • Muir R.
        • et al.
        Early mucosal healing with exclusive enteral nutrition is associated with improved outcomes in newly diagnosed children with luminal Crohn's disease.
        J Crohns Colitis. 2016; 10: 1159-1164
        • Grover Z.
        • Muir R.
        • Lewindon P.
        Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease.
        J Gastroenterol. 2014; 49: 638-645
        • Forbes A.
        • Escher J.
        • Hébuterne X.
        • et al.
        ESPEN guideline: clinical nutrition in inflammatory bowel disease.
        Clin Nutr. 2017; 36: 321-347
        • Critch J.
        • Day A.S.
        • Otley A.
        • et al.
        Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease.
        J Pediatr Gastroenterol Nutr. 2012; 54: 298-305
        • Carroll M.W.
        • Kuenzig M.E.
        • Mack D.R.
        • et al.
        The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD.
        J Can Assoc Gastroenterol. 2019; 2: S49-S67
        • Rubalcava N.S.
        • Moreno N.A.
        • Adler J.
        • et al.
        Does the timing of pouch creation in 2-stage operations for pediatric patients with ulcerative colitis matter?.
        Journal of Pediatric Surgery. 2021; 56: 1203-1207https://doi.org/10.1016/j.jpedsurg.2021.02.023